A critical breakthrough in cancer research is emerging with the use of mini-antibodies to restore mutated p53. This essential tumor inhibitor protein is frequently disabled in several kinds of malignancies, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research